Valirx Plc (VAL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 84 | -32 | 14 | -1,072 | 95 |
| Other Working Capital | 430 | -536 | 69 | -272 | -105 |
| Other Operating Activity | -1,856 | -2,785 | -2,434 | -2,852 | -2,580 |
| Operating Cash Flow | $-1,342 | $-3,354 | $-2,351 | $-4,196 | $-2,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 3 | -32 |
| Net Acquisitions | N/A | N/A | 0 | 857 | N/A |
| Sale Of Investment | 147 | N/A | N/A | N/A | 0 |
| Purchase Sale Intangibles | -397 | -324 | -280 | -387 | -390 |
| Other Investing Activity | 0 | 0 | 74 | 141 | 110 |
| Investing Cash Flow | $-250 | $-324 | $-206 | $615 | $-311 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -138 | -25 | -84 | 2,993 | N/A |
| Common Stock Issued | 1,576 | 3,720 | 3,068 | 1,696 | 3,050 |
| Other Financing Activity | -225 | -346 | -286 | -780 | -369 |
| Financing Cash Flow | $1,213 | $3,349 | $2,698 | $3,909 | $2,681 |
| Beginning Cash Position | 373 | 701 | 561 | 232 | 453 |
| End Cash Position | -6 | 373 | 701 | 561 | 232 |
| Net Cash Flow | $-379 | $-329 | $141 | $328 | $-220 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,342 | -3,354 | -2,351 | -4,196 | -2,590 |
| Capital Expenditure | -397 | -324 | -280 | -387 | -422 |
| Free Cash Flow | -1,738 | -3,678 | -2,632 | -4,582 | -3,012 |